Times of crisis overwhelmingly bring out the good in society, however they also see the fakes and counterfitters crawl out from their shadowy world. With huge potential profits to be gained in the relatively short time that people are panicking there really is no better time to be extra cautious across our industry.

At QUINTA-ANALYTICA we take quality seriously not just in these unprecedented times, but ALL the time.  Quinta’s CCO Jiri Raska, explains “despite not being drug manufacturers per se, we’ve got our partners covered in all aspects of the services we provide to them, and we pride ourselves in the integrity of our end-to-end operations”.

The European Medicines Agency guidelines explain how checking the label, especially when buying online, is key to staying one step ahead, and this helpful post from the EFPIA – European Federation of Pharmaceutical Industries and Associations  goes further to breakdown the risk.

Additional News

  • 3 September 2026

    Quinta-Analytica Expands HPLC Fleet to Strengthen Flexibility and Capacity for Clients

    New Thermo Scientific Vanquish Core joins an HPLC fleet of around 50 systems

  • 7 August 2026

    Quinta-Analytica at CPHI Milan 2026 – Meet Us at Conscio Group Stand 6N25

    Meet Quinta-Analytica at CPHI Milan 2026 as part of the Conscio Group team at Stand 6N25. Discuss your clinical, bioanalytical and analytical projects with our experts and arrange a meeting in advance.

  • 15 July 2026

    Quinta-Analytica Awarded the EcoVadis Gold Medal

    Quinta-Analytica has been awarded the EcoVadis Gold Medal after achieving an overall sustainability score of 84 out of 100. The result represents a substantial increase from 68 points in the previous assessment and places the company in the 97th percentile globally.